[1] Ta HT, Dass CR, Choong PFM, et al. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev, 2009; 28, 247−63. doi:  10.1007/s10555-009-9186-7
[2] Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med, 1994; 118, 371−9.
[3] Hansen E, Pawlik M, Altmeppen J, et al. Advantages of intraoperative blood salvage with blood irradiation in cancer surgery. Transf Med Chemother, 2004; 31, 286−92. doi:  10.1159/000080415
[4] Masuda T, Hayashi N, Iguchi T, et al. Clinical and biological significance of circulating tumor cells in cancer. Mol Oncol, 2016; 10, 408−17. doi:  10.1016/j.molonc.2016.01.010
[5] Zhang HQ, Li MH, Wang Z, et al. Detection and clinical significance of circulating tumor cells in osteosarcoma using immunofluorescence combined with in situ hybridization. Chin J Oncol, 2017; 39, 485−9. (In Chinese
[6] Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res, 2004; 10, 6897−904. doi:  10.1158/1078-0432.CCR-04-0378
[7] Zhong GX, Feng SD, Shen RK, et al. The clinical significance of the Ezrin gene and circulating tumor cells in osteosarcoma. Onco Targets Ther, 2017; 10, 527−33. doi:  10.2147/OTT.S125589
[8] Niinaka Y, Harada K, Fujimuro M, et al. Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis. Cancer Res, 2010; 70, 9483−93. doi:  10.1158/0008-5472.CAN-09-3880
[9] Kumar N, Zaw AS, Khoo BL, et al. Intraoperative cell salvage in metastatic spine tumour surgery reduces potential for reinfusion of viable cancer cells. Eur Spine J, 2016; 25, 4008−15. doi:  10.1007/s00586-016-4478-4
[10] Chen HM, Cao BS, Sun B, et al. Highly-sensitive capture of circulating tumor cells using micro-ellipse filters. Sci Rep, 2017; 7, 610. doi:  10.1038/s41598-017-00232-6
[11] Adamopoulos C, Gargalionis AN, Piperi C, et al. Recent advances in mechanobiology of osteosarcoma. J Cell Biochem, 2017; 118, 232−6. doi:  10.1002/jcb.25660
[12] Krebs MG, Metcalf RL, Carter L, et al. Molecular analysis of circulating tumour cells-biology and biomarkers. Nat Rev Clin Oncol, 2014; 11, 129−44. doi:  10.1038/nrclinonc.2013.253
[13] Pantel K, Speicher MR. The biology of circulating tumor cells. Oncogene, 2016; 35, 1216−24. doi:  10.1038/onc.2015.192
[14] Cristofanilli M. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Semin Oncol, 2006; 33, S9−14. doi:  10.1053/S0093-7754(06)00219-3